Phibro Animal Health Corporation Class A (PAHC)

Nasdaq Market Closed

Phibro Animal Health Corporation is a diversified animal health and nutrition company serving livestock producers, veterinarians, feed manufacturers, and agricultural distributors. Its products are used in the care and productivity of food animals, including poultry, swine, beef cattle, dairy cattle, and aquaculture species, giving the company exposure to global protein production and food supply chains.

The company operates through three main segments: Animal Health, Mineral Nutrition, and Performance Products. Animal Health is the core business and includes antibacterials, anticoccidials, vaccines, and nutritional specialty products designed to support animal well-being, disease prevention, feed efficiency, and overall herd or flock performance. These products are used in commercial farming systems where animal health, consistency, and productivity are central to profitability.

Phibro’s Mineral Nutrition segment supplies trace minerals and related ingredients that are incorporated into animal feed. These inputs help address nutritional requirements that vary by species, stage of growth, and production system. The Performance Products segment includes specialty ingredients and industrial products that broaden the company’s revenue base beyond its principal animal health franchise.

The company sells in the United States and international markets, reflecting the global nature of livestock and aquaculture production. Demand for its portfolio is shaped by meat, milk, egg, and fish consumption, disease pressures, farm economics, feed costs, and regulatory rules governing animal health products. Phibro’s distinctive position lies in combining pharmaceuticals, vaccines, feed additives, and nutritional technologies for production animals, rather than focusing solely on companion animal care or human healthcare.

31.79 USD
31.17 USD
+3.27 (+11.47%)
After-hours

Last updated

Market Cap
1.16B
P/E
12.15
P/FCF
90.59
P/S
0.77
Enterprise Value
1.84B
Sector
Health Care
Industry
Pharmaceutical Preparations
Address
GLENPOINTE CENTRE EAST, 3RD FLOOR, TEANECK, NJ, 07666
GlobeNewswire Inc.

Glycolic Acid Market is expected to generate a revenue of USD 461.74 Million by 2032, Globally, at 5.73% CAGR: Verified Market Research®

14 Jan 2026, 03:45 AM
GlobeNewswire Inc.

Poultry Vaccine & Drug Market Booming as Demand for Disease Prevention Increases

14 Feb 2025, 15:57 PM
GlobeNewswire Inc.

Growth Trends in the Porcine Vaccines Market, Forecast to 2028: Increasing Government Initiatives for Funding Animal Husbandry

08 Jan 2025, 15:55 PM
GlobeNewswire Inc.

UAE Veterinary Medicine Market, By Region, Competition, Forecast and Opportunities, 2029F

20 Sept 2024, 09:54 AM
GlobeNewswire Inc.

Animal Feed Minerals Market Set to Grow at 3.9% CAGR from 2024 to 2034, Reaching USD 6.1 Billion | Future Market Insights, Inc.

17 Sept 2024, 01:30 AM
GlobeNewswire Inc.

Poultry Vaccines Market Size and Forecast, Global and Regional Share, Trends, and Growth Opportunity Analysis Report 2024

29 Aug 2024, 09:50 AM
Zacks Investment Research

Is Phibro (PAHC) Stock Worth Retaining in Your Portfolio Now?

05 Aug 2024, 12:52 PM
GlobeNewswire Inc.

Global Swine Healthcare Market Size To Worth USD 5.96 Billion By 2033 | CAGR of 8.16% - GlobeNewswire

23 Jul 2024, 23:01 PM
Zacks Investment Research

Zacks Value Trader Highlights: Great Lakes Dredge & Dock, HanesBrands, Lands' End, Phibro Animal Health and Wolverine World Wide - Zacks Investment Research

22 Jul 2024, 16:08 PM
Zacks Investment Research

How to Invest in Small Cap Value Stocks in 2024 - Zacks Investment Research

19 Jul 2024, 19:26 PM
Zacks Investment Research

Beat the Market Like Zacks: Freshpet, AudioEye, Walmart in Focus

24 Jun 2024, 13:10 PM
Zacks Investment Research

Phibro (PAHC) Upgraded to Strong Buy: What Does It Mean for the Stock?

20 Jun 2024, 17:00 PM
Zacks Investment Research

Is Phibro Animal Health (PAHC) Stock Undervalued Right Now?

14 Jun 2024, 14:40 PM
Zacks Investment Research

Phibro (PAHC) Down 3.3% Since Last Earnings Report: Can It Rebound?

07 Jun 2024, 16:30 PM
Zacks Investment Research

Should Value Investors Buy Phibro Animal Health (PAHC) Stock?

29 May 2024, 14:40 PM
Zacks Investment Research

Haemonetics Corporation (HAE) Hit a 52 Week High, Can the Run Continue?

14 May 2024, 14:15 PM
Zacks Investment Research

Are Investors Undervaluing Phibro Animal Health (PAHC) Right Now?

13 May 2024, 14:40 PM
Zacks Investment Research

Interpreting Phibro (PAHC) International Revenue Trends

13 May 2024, 13:46 PM
Zacks Investment Research

Phibro (PAHC) Q3 Earnings and Revenues Beat, Gross Margin Down

09 May 2024, 15:18 PM
Zacks Investment Research

Phibro (PAHC) Reports Q3 Earnings: What Key Metrics Have to Say

09 May 2024, 01:00 AM
Market Cap
1.16B
Enterprise Value
1.84B
P/E
12.15
P/B
3.2
P/S
0.77
EV / EBITDA
7.97
EV / Sales
1.22
EPS
2.35
Dividend Yield
1.68%
P/FCF
90.59
P/CF
17.49
Free Cash Flow
12.77M
ROE
26.32%
ROA
6.59%
Debt / Equity
2.03
Current Ratio
3.17
Quick Ratio
1.26
Cash
0.19
Avg Volume
421.42K
Fundamentals Snapshot Price
28.52

Income Statement

Line Item 2026 Q3 2026 Q2 2026 Q1 2025 Q4 2025 Q3
Revenue 383.54M 373.91M 363.89M 378.7M 347.83M
Gross profit 125.68M 132.66M 119.78M 110.01M 104.57M
Operating income 44.65M 50.33M 51.26M 33.72M 33.52M
EBITDA 57.1M 63.22M 64.09M 46.13M 46.13M
Net income 24.02M 27.46M 26.53M 17.22M 20.88M
Basic EPS 0.59 0.68 0.65 0.42 0.52
Diluted EPS 0.59 0.67 0.65 0.43 0.51

Balance Sheet

Line Item 2026 Q3 2026 Q2 2026 Q1 2025 Q4 2025 Q3
Total assets 1.45B 1.41B 1.39B 1.36B 1.32B
Total liabilities 1.08B 1.07B 1.07B 1.08B 1.05B
Total equity 361.83M 332.36M 311.68M 285.68M 265.99M
Cash & equivalents 54.93M 55.49M 72.77M 68.04M 60.35M
Current assets 894.07M 862.19M 835.8M 810.61M 776.02M
Current liabilities 281.87M 282.37M 270.14M 293.47M 266.48M

Cash Flow

Line Item 2026 Q3 2026 Q2 2026 Q1 2025 Q4 2025 Q3
Operating cash flow 16.21M 19.35M 9.3M 21.27M 43.15M
Investing cash flow -16.81M -17.18M -21.01M -7.03M -18.25M
Financing cash flow -2.3M -18.98M 16.34M -7.77M -32.22M
Change in cash -557K -17.28M 4.73M 7.69M -6.72M
Kind Filing Date Link
edgar index SCHEDULE 13D/A — PHIBRO ANIMAL HEALTH CORP View Filing
edgar index SCHEDULE 13G/A — PHIBRO ANIMAL HEALTH CORP View Filing
edgar index 4 — PHIBRO ANIMAL HEALTH CORP View Filing
form 4 Form 4 — BENDHEIM JACK View Filing
form 4 Form 4 — BFI Co., LLC View Filing
form 4 Form 4 — BFI Co., LLC View Filing
form 4 Form 4 — BENDHEIM JACK View Filing
form 4 Form 4 — BENDHEIM JACK View Filing
form 4 Form 4 — BFI Co., LLC View Filing
edgar index 10-Q — PHIBRO ANIMAL HEALTH CORP View Filing
edgar index 8-K — PHIBRO ANIMAL HEALTH CORP View Filing
eight k text 8-K — 8-K View Filing
form 4 Form 4 — BFI Co., LLC View Filing
form 4 Form 4 — BENDHEIM JACK View Filing
form 4 Form 4 — BFI Co., LLC View Filing
form 4 Form 4 — BENDHEIM JACK View Filing
edgar index 8-K — PHIBRO ANIMAL HEALTH CORP View Filing
eight k text 8-K — 8-K View Filing
form 4 Form 4 — BFI Co., LLC View Filing
form 4 Form 4 — BENDHEIM JACK View Filing
form 4 Form 4 — BFI Co., LLC View Filing
form 4 Form 4 — BFI Co., LLC View Filing
form 4 Form 4 — BENDHEIM JACK View Filing
form 4 Form 4 — BENDHEIM JACK View Filing
edgar index 8-K — PHIBRO ANIMAL HEALTH CORP View Filing
eight k text 8-K — 8-K View Filing
edgar index 4 — PHIBRO ANIMAL HEALTH CORP View Filing
edgar index SCHEDULE 13D/A — PHIBRO ANIMAL HEALTH CORP View Filing
form 4 Form 4 — BENDHEIM JACK View Filing
form 4 Form 4 — BFI Co., LLC View Filing
form 4 Form 4 — BENDHEIM JACK View Filing
form 4 Form 4 — BFI Co., LLC View Filing
form 4 Form 4 — BENDHEIM JACK View Filing
form 4 Form 4 — BFI Co., LLC View Filing
form 4 Form 4 — BFI Co., LLC View Filing
form 4 Form 4 — BENDHEIM JACK View Filing
form 4 Form 4 — BFI Co., LLC View Filing
form 4 Form 4 — BENDHEIM JACK View Filing
form 4 Form 4 — BFI Co., LLC View Filing
form 4 Form 4 — BENDHEIM JACK View Filing
edgar index 4 — PHIBRO ANIMAL HEALTH CORP View Filing
form 4 Form 4 — BENDHEIM JACK View Filing
form 4 Form 4 — BENDHEIM JACK View Filing
form 4 Form 4 — BFI Co., LLC View Filing
form 4 Form 4 — BENDHEIM JACK View Filing
form 4 Form 4 — BFI Co., LLC View Filing
form 4 Form 4 — BFI Co., LLC View Filing
form 4 Form 4 — BENDHEIM JACK View Filing
form 4 Form 4 — BFI Co., LLC View Filing
form 4 Form 4 — BENDHEIM JACK View Filing
form 4 Form 4 — BENDHEIM JACK View Filing
form 4 Form 4 — BFI Co., LLC View Filing
form 4 Form 4 — BENDHEIM JACK View Filing
form 4 Form 4 — BFI Co., LLC View Filing
form 4 Form 4 — BFI Co., LLC View Filing
edgar index 8-K — PHIBRO ANIMAL HEALTH CORP View Filing
eight k text 8-K — 8-K View Filing
form 4 Form 4 — BENDHEIM JACK View Filing
form 4 Form 4 — BFI Co., LLC View Filing
form 4 Form 4 — BFI Co., LLC View Filing
form 4 Form 4 — BENDHEIM JACK View Filing
form 4 Form 4 — BENDHEIM JACK View Filing
form 4 Form 4 — BFI Co., LLC View Filing
edgar index SCHEDULE 13G — PHIBRO ANIMAL HEALTH CORP View Filing
edgar index SCHEDULE 13G/A — PHIBRO ANIMAL HEALTH CORP View Filing
edgar index 4 — PHIBRO ANIMAL HEALTH CORP View Filing
form 4 Form 4 — BENDHEIM JACK View Filing
form 4 Form 4 — BENDHEIM JACK View Filing
form 4 Form 4 — BFI Co., LLC View Filing
form 4 Form 4 — BFI Co., LLC View Filing
form 4 Form 4 — BFI Co., LLC View Filing
form 4 Form 4 — BFI Co., LLC View Filing
form 4 Form 4 — BFI Co., LLC View Filing
form 4 Form 4 — BENDHEIM JACK View Filing
form 4 Form 4 — BENDHEIM JACK View Filing